Co-crystals of the antiretroviral nevirapine: crystal structures, thermal analysis and dissolution behaviour

被引:45
作者
Caira, Mino R. [1 ]
Bourne, Susan A. [1 ]
Samsodien, Halima [1 ]
Engel, Emile [1 ]
Liebenberg, Wilna [2 ]
Stieger, Nicole [2 ]
Aucamp, Marique [2 ]
机构
[1] Univ Cape Town, Dept Chem, Ctr Supramol Chem Res, ZA-7701 Rondebosch, South Africa
[2] North West Univ, Unit Drug Res & Dev, Fac Hlth Sci, Potchefstroom, South Africa
基金
新加坡国家研究基金会;
关键词
X-RAY; SOLUBILITY; COCRYSTALS; INCLUSION;
D O I
10.1039/c2ce06507j
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Synthesis and physicochemical characterization of co-crystals of the antiretroviral drug nevirapine (NV) with the pharmaceutically acceptable co-formers saccharin, rac-tartaric acid, maleic acid, glutaric acid and salicylic acid are reported for the first time. The respective stoichiometric NV : co-former ratios are 2 : 1, 1 : 1, 1 : 1, 1 : 1 and 2 : 1. In the 1 : 1 co-crystals, the predicted R-2(2)(8) NV(amide)carboxylic acid supramolecular synthon occurs, whereas in the 2 : 1 species, the co-former is H-bonded to a centrosymmetric NV dimer formed via the R-2(2)(8) amide-amide synthon. Thermal analysis of three co-crystals revealed the unusual phenomenon of precipitation of NV from the melt. Co-crystallization of NV with maleic acid led to the highest (similar to fivefold) increase in the aqueous solubility of the drug.
引用
收藏
页码:2541 / 2551
页数:11
相关论文
共 29 条
[1]  
[Anonymous], 1999, SAINT VERS 6 02 INCL
[2]   SYNTHESIS, CRYSTAL-STRUCTURE, AND VIBRATIONAL-SPECTRA OF THE COMPLEX MALEIC ACID.2H2O.18-CROWN-6 [J].
AUDET, P ;
SAVOIE, R ;
SIMARD, M .
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1990, 68 (12) :2183-2189
[3]   In situ co-crystallisation as a tool for low-temperature crystal engineering [J].
Bond, AD .
CHEMICAL COMMUNICATIONS, 2003, (02) :250-251
[4]  
British Pharmacopoeia, 2005, BRIT PHARM
[5]  
Byrn S.R., 1999, Solid State Chemistry of Drugs, VSecond
[6]   Solvent inclusion by the anti-HIV drug nevirapine: X-ray structures and thermal decomposition of representative solvates [J].
Caira, Mino R. ;
Stieger, Nicole ;
Liebenberg, Wilna ;
De Villieris, Melgardt M. ;
Samsodien, Halima .
CRYSTAL GROWTH & DESIGN, 2008, 8 (01) :17-23
[7]   The Reemergence of Cocrystals: The Crystal Clear Writing Is on the Wall Introduction to Virtual Special Issue on Pharmaceutical Cocrystals [J].
Childs, Scott L. ;
Zaworotko, Michael J. .
CRYSTAL GROWTH & DESIGN, 2009, 9 (10) :4208-4211
[8]   Benefits of cocrystallisation in pharmaceutical materials science: an update [J].
Friscic, Tomislav ;
Jones, William .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (11) :1547-1559
[9]   Solubility Advantage of Pharmaceutical Cocrystals [J].
Good, David J. ;
Rodriguez-Hornedo, Nair .
CRYSTAL GROWTH & DESIGN, 2009, 9 (05) :2252-2264
[10]  
Griesser U. J., 2006, POLYMORPHISM PHARM I, DOI DOI 10.1002/3527607889.CH8